The life sciences encompass research fields that have a direct impact on our quality of our health, food and environment including pharmaceuticals, genetics, systems biology and biotechnology. Now, in the post-genomic era, the domain has undergone a revolution in terms of research approaches, new infrastructure needs and technology developments and, now more than ever, we are witnessing new developments which directly impact on our lives.
These developments are taking place throughout the world and, in order for Europe to remain competitive with the US and Asia, the necessary critical mass of expertise and resources must be made available in a coordinated manner. Currently, R & D investment is fragmented among numerous funding bodies across Europe. Now, with support from the European Commission, the ESF will launch this unique initiative to bring together these funding bodies and life sciences researchers to develop a more coordinated strategy for planning and investing in life sciences research. The establishment of EuroBioFund is well timed given that the EU’s New Seventh Framework Programme (FP7), will be launched officially as of January 1 2007, with a budget of €50 billion to invest in scientific research and innovation.
The three key objectives of the EuroBioFund are:
1. Provide a platform for funding organisations and life science researchers to foster joint research initiatives through networking and brokerage: EuroBioForum
2. Help organise research communities and facilitate bottom-up generation of research programmes of European scale and scope: EuroBioGenerator
3. Shape a new funding way in Europe by helping to develop joint investments and funding of life sciences research: EuroBioAccess
EuroBioFund’s new approach will centre on an annual conference, EuroBioForum, and the first will be held in Helsinki 14-15 December 2006. For funders this is a unique opportunity to engage with key life science research groups presenting proposals for cutting-edge pan-European research programmes. From the researcher’s side, EuroBioForum provides a forum to promote important research topics to those funding and investing in life sciences R & D.
‘Moving toward a more coordinated approach to R & D investment in the life sciences is a challenging but necessary step if Europe is to remain an important global player in life sciences and biotechnology research,’ says Wouter Spek, Director of EuroBioFund.
Wouter Spek | Source: alphagalileo
Further information: www.esf.org
www.esf.org/esf_pressarea_page.php?language=0§ion=6&year=2006&newsrelease=121
Further Reports about: EuroBioFund > Funding > launch
More articles from Life Sciences:
Scientists Unravel Evolution of Highly Toxic Box Jellyfish
20.11.2009 | NOAA Fisheries Northeast Fisheries Science Center
Texas A&M Researchers Examine How Viruses Destroy Bacteria
20.11.2009 | Texas A&M University
Scientists Unravel Evolution of Highly Toxic Box Jellyfish
20.11.2009 | Life Sciences
When good companies do bad things: Examining illegal corporate behavior
20.11.2009 | Business and Finance
UCR plant scientist's research spawns new discoveries showing how crops survive drought
20.11.2009 | Agricultural and Forestry Science
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News